These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 30867580)

  • 1. Host tissue determinants of tumour immunity.
    Salmon H; Remark R; Gnjatic S; Merad M
    Nat Rev Cancer; 2019 Apr; 19(4):215-227. PubMed ID: 30867580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    Harper J; Sainson RC
    Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical role of the TME in solid cancer.
    Giraldo NA; Sanchez-Salas R; Peske JD; Vano Y; Becht E; Petitprez F; Validire P; Ingels A; Cathelineau X; Fridman WH; Sautès-Fridman C
    Br J Cancer; 2019 Jan; 120(1):45-53. PubMed ID: 30413828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
    Oliver AJ; Lau PKH; Unsworth AS; Loi S; Darcy PK; Kershaw MH; Slaney CY
    Front Immunol; 2018; 9():70. PubMed ID: 29445373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development.
    Ochoa de Olza M; Navarro Rodrigo B; Zimmermann S; Coukos G
    Lancet Oncol; 2020 Sep; 21(9):e419-e430. PubMed ID: 32888471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
    Nagarsheth N; Wicha MS; Zou W
    Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-host interactions through the lens of Drosophila.
    Bilder D; Ong K; Hsi TC; Adiga K; Kim J
    Nat Rev Cancer; 2021 Nov; 21(11):687-700. PubMed ID: 34389815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.
    Chkourko Gusky H; Diedrich J; MacDougald OA; Podgorski I
    Obes Rev; 2016 Nov; 17(11):1015-1029. PubMed ID: 27432523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
    Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Exercise on the Tumour Microenvironment.
    Buss LA; Dachs GU
    Adv Exp Med Biol; 2020; 1225():31-51. PubMed ID: 32030646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and biology of tumour associated stromal cells.
    Raffaghello L; Dazzi F
    Immunol Lett; 2015 Dec; 168(2):175-82. PubMed ID: 26145459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Site and the Cancer Immunity Cycle.
    Horton BL; Fessenden TB; Spranger S
    Trends Cancer; 2019 Oct; 5(10):593-603. PubMed ID: 31706507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of the cell-mediated immune response to tumour growth.
    López ÁG; Seoane JM; Sanjuán MAF
    Philos Trans A Math Phys Eng Sci; 2017 Jun; 375(2096):. PubMed ID: 28507236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning cancer fate: the unremitting role of host immunity.
    Calì B; Molon B; Viola A
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the tumour microenvironment.
    Laplane L; Duluc D; Bikfalvi A; Larmonier N; Pradeu T
    Int J Cancer; 2019 Nov; 145(10):2611-2618. PubMed ID: 30989643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From mice to humans: developments in cancer immunoediting.
    Teng MW; Galon J; Fridman WH; Smyth MJ
    J Clin Invest; 2015 Sep; 125(9):3338-46. PubMed ID: 26241053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells, plasma cells and antibody repertoires in the tumour microenvironment.
    Sharonov GV; Serebrovskaya EO; Yuzhakova DV; Britanova OV; Chudakov DM
    Nat Rev Immunol; 2020 May; 20(5):294-307. PubMed ID: 31988391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of cancer formation by intrinsic genetic noise and microenvironmental cues.
    Brock A; Krause S; Ingber DE
    Nat Rev Cancer; 2015 Aug; 15(8):499-509. PubMed ID: 26156637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.